Resultados de Búsqueda

NICE

National Institute for Health and Clinical Excellence (NICE)

The case for adopting the iFuse implant system to treat chronic sacroiliac joint pain is supported by the evidence. Using iFuse leads to improved pain relief, better quality of life and less disability compared with non-surgical management. iFuse should be considered for use in people with a confirmed diagnosis of chronic sacroiliac joint pain (based on clinical assessment and a positive response to a diagnostic injection of local anaesthetic in the sacroiliac joint) and whose pain is ...

NICE

National Institute for Health and Clinical Excellence (NICE)

This procedure should only be done by a surgeon with specific training in the procedure, who should carry out their initial procedures with an experienced mentor. Clinicians should enter data onto the British Spine Registry.

NICE

National Institute for Health and Clinical Excellence (NICE)

Base decisions on the timing of regular clinical reviews and follow‑up imaging for people with meningioma on: any residual tumour, life expectancy, the person's preferences, treatments used before, treatment options available, tumour grade. Consider standard structural MRI (defined as T2 weighted, FLAIR, DWI series and T1 pre- and post-contrast volume) as part of regular clinical review for people with meningioma, to assess for progression or recurrence, unless MRI is contraindicated. For ...

NICE

National Institute for Health and Clinical Excellence (NICE)

Consider CT imaging for meningioma (if not already performed) to assess bone involvement if this is suspected. Evidence indicated that standard structural MRI is useful in distinguishing high-grade from low-grade glioma, and the committee agreed that it is appropriate to extrapolate from this evidence to a belief that MRI can be used to distinguish meningioma from healthy brain tissue. In the committee's experience, CT scans can be more accurate than MRI for assessing meningioma with bone ...

NICE

National Institute for Health and Clinical Excellence (NICE)

Base decisions on the timing of regular clinical reviews and follow‑up imaging for people with glioma on: any residual tumour, life expectancy, the person's preferences ,treatments used before, treatment options available, tumour subtype. Consider standard structural MRI (defined as T2 weighted, FLAIR, DWI series and T1 pre- and post-contrast volume) as part of regular clinical review for people with glioma, to assess for progression or recurrence, unless MRI is contraindicated. Consider ...